Lysosomal rupture induced by structurally distinct chitosans either promotes a type 1 IFN response or activates the inflammasome in macrophages

Biomaterials. 2017 Jun:129:127-138. doi: 10.1016/j.biomaterials.2017.03.022. Epub 2017 Mar 15.

Abstract

Chitosan is a family of glucosamine and N-acetyl glucosamine polysaccharides with poorly understood immune modulating properties. Here, functional U937 macrophage responses were analyzed in response to a novel library of twenty chitosans with controlled degree of deacetylation (DDA, 60-98%), molecular weight (1 to >100 kDa), and acetylation pattern (block vs. random). Specific chitosan preparations (10 or 190 kDa 80% block DDA and 3, 5, or 10 kDa 98% DDA) either induced macrophages to release CXCL10 and IL-1ra at 5-50 μg/mL, or activated the inflammasome to release IL-1β and PGE2 at 50-150 μg/mL. Chitosan induction of these factors required lysosomal acidification. CXCL10 production was preceded by lysosomal rupture as shown by time-dependent co-localization of galectin-3 and chitosan and slowed autophagy flux, and specifically depended on IFN-β paracrine activity and STAT-2 activation that could be suppressed by PGE2. Chitosan induced a type I IFN paracrine response or inflammasome response depending on the extent of lysosomal rupture and cytosolic foreign body invasion. This study identifies the structural motifs that lead to chitosan-driven cytokine responses in macrophages and indicates that lysosomal rupture is a key mechanism that determines the endogenous release of either IL-1ra or IL-1β.

Keywords: Chitin/chitosan; Immunomodulation; Inflammasome; Macrophage; Type 1 interferon.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetylation
  • Chemokine CXCL12 / metabolism
  • Chitosan / chemistry
  • Chitosan / pharmacology*
  • Dinoprostone / metabolism
  • Humans
  • Inflammasomes / metabolism*
  • Interferon Type I / metabolism*
  • Interleukin 1 Receptor Antagonist Protein / metabolism
  • Interleukin-1beta / metabolism
  • Lysosomes / drug effects
  • Lysosomes / pathology*
  • Macrophages / drug effects
  • Macrophages / metabolism*
  • Proton Magnetic Resonance Spectroscopy
  • U937 Cells

Substances

  • Chemokine CXCL12
  • Inflammasomes
  • Interferon Type I
  • Interleukin 1 Receptor Antagonist Protein
  • Interleukin-1beta
  • Chitosan
  • Dinoprostone

Grants and funding